Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
NCT05171478 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2025-12-17
Summary
This study sets out to register imaging of small biopsy specimens obtained during bronchoscopy using full-field optical coherence tomography against standard histologic evaluation.
Conditions
- Lung Cancer
- Sarcoidosis
Interventions
- DIAGNOSTIC_TEST
-
Full-field optical coherence tomography
Sample obtained during bronchoscopy will be imaged using full-field optical coherence tomography
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jeffrey Thiboutot, MD · Johns Hopkins University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-09
- Primary Completion
- 2026-12-08
- Completion
- 2026-12-08
Countries
- United States
Study Locations
More Related Trials
-
A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer
NCT04951154 ·Status: COMPLETED
-
EB-OCT Biopsy Guidance of Lung Cancer
NCT06556680 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
NCT02117440 ·Status: TERMINATED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
NCT01039311 ·Status: TERMINATED
-
Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy
NCT03116633 ·Status: COMPLETED
-
WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC
NCT03481101 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study
NCT07045103 ·Status: RECRUITING
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Ex-Vivo COF Study for Lung Cancer Observation
NCT04534413 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions:A Preliminary Lung Centered Study
NCT04960631 ·Status: COMPLETED
-
Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer
NCT05260606 ·Status: RECRUITING
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer
NCT03721120 ·Status: COMPLETED ·Phase: NA
-
Surveillance For New Lung Primaries
NCT00205439 ·Status: TERMINATED
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Computed Tomography (CT) Perfusion Imaging of Lung Cancer
NCT00905801 ·Status: TERMINATED ·Phase: NA
-
Benefit of Spectral Information in Patients Suspected for Lung Cancer
NCT06440616 ·Status: RECRUITING ·Phase: NA
-
Improving the Early Detection of Lung Cancer by Combining Exosomal Analysis of Hypoxia With Standard of Care Imaging
NCT04629079 ·Status: UNKNOWN
-
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
NCT03563976 ·Status: RECRUITING
-
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites
NCT04474613 ·Status: TERMINATED ·Phase: NA
-
Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease
NCT01396603 ·Status: COMPLETED
-
Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation Microscope
NCT06007261 ·Status: RECRUITING